UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP issued a solicitation reminding UNCY investors of a lead plaintiff deadline of November 2, 2026 in a securities fraud class action covering the period December 29, 2025 to June 29, 2026. The complaint alleges Unicycive failed to inspect its third-party manufacturing partner for GMP compliance and lacked support for claims that FDA-identified deficiencies were resolved.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.